Search

Compugen Ltd

Uždarymo kaina

1.91 -5.45

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.98

Max

2.04

Pagrindiniai rodikliai

By Trading Economics

Pajamos

663K

-7M

Pardavimai

426K

2.6M

P/E

Sektoriaus vid.

5.211

51.78

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-269.254

Darbuotojai

75

EBITDA

665K

-7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+123.88% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-09

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-38M

188M

Ankstesnė atidarymo kaina

7.36

Ankstesnė uždarymo kaina

1.91

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-11-04 23:56; UTC

KBR Inc shares are down significantly in after-market trading, falling to their lowest point of the day.

2026-11-04 23:56; UTC

News
Social Media

Trimble Inc appoints Matthew C. Brown, former CFO of Tenable Holdings, to its Board of Directors in after-market trading.

2026-11-04 23:56; UTC

Correlated Moves

D.R. Horton, Inc. shares traded modestly lower in after-market hours, while Amcor PLC's sharp decline followed disappointing Q1 results and lowered EPS guidance.

2026-11-04 23:56; UTC

Hims & Hers Health, Inc. is trading modestly higher in after-market hours following an increase during the session.

2026-11-04 23:56; UTC

Correlated Moves

Lattice Semiconductor Corporation shares declined in after-market trading, continuing a downward trend since Wednesday's close and nearing the lower end of their one-month range.

2026-11-04 23:56; UTC

IES Holdings Inc shares rose significantly during after-market hours on Wednesday, recovering from a recent decline and moving higher following the close of regular trading.

2026-11-04 23:56; UTC

Synopsys, Inc. shares are trading modestly higher in after-market hours, recovering from earlier lows after four consecutive daily declines.

2026-11-04 23:52; UTC

News

Uranium Energy Corp. is trading modestly higher in after-market hours following fluctuations since Wednesday's close.

2026-11-04 23:51; UTC

Kontoor Brands, Inc. is trading lower in after-market hours, retreating from a brief uptick and remaining at the lower end of its recent range.

2026-11-04 23:51; UTC

GE HealthCare Technologies Inc. is trading modestly higher in after-market hours, despite a slight decline from earlier session highs.

2026-11-04 23:51; UTC

Mondelez International, Inc. shares have advanced modestly in after-market hours, remaining near the upper end of their one-month range.

2026-11-04 23:51; UTC

Avient Corp is declining in after-market trading, falling to its lowest point of the day.

2026-11-04 23:51; UTC

Lindsay Corporation's shares traded modestly lower during after-market hours on Wednesday, remaining around the midpoint of their one-month trading range.

2026-11-04 23:51; UTC

News

Watts Water Technologies reports Q3 net sales of $728 million, exceeding estimates, with diluted EPS of $4.34 and raises full-year sales growth outlook to 17%-18%.

2026-11-04 23:51; UTC

Twist Bioscience Corporation shares declined during after-market hours on Wednesday, reversing a trend of higher daily closes observed in recent sessions.

2026-11-04 23:51; UTC

Wendy's Co shares are declining in after-market trading, reflecting pronounced losses despite a strong recent performance and seven consecutive sessions of higher closes.

2026-11-04 23:51; UTC

Delta Air Lines, Inc. shares are trading lower in after-market hours, pulling back from earlier gains.

2026-11-04 23:51; UTC

Correlated Moves

Clorox Company shares are modestly lower in after-market trading, following a brief peak earlier in the session.

2026-11-04 23:51; UTC

BlackRock, Inc. shares traded modestly lower in after-market hours, retracing from an early session peak.

2026-11-04 23:51; UTC

Correlated Moves

Vertiv Holdings Co is modestly higher in after-market trading, moving in sympathy with Eaton Corporation PLC following strong third-quarter results.

2026-11-04 23:51; UTC

Redwood Trust, Inc. shares declined during after-market trading on Wednesday, moving notably lower from a modest high shortly after the market closed.

2026-11-04 23:46; UTC

News
Correlated Moves

Chord Energy reports Q3 adjusted EPS of $6.08, exceeding estimates, while revenues of $1.71B missed expectations; raises 2026 adjusted EBITDA guidance to $3.4B.

2026-11-04 23:46; UTC

Martin Marietta Materials, Inc. is trading modestly higher in after-market hours, reaching its highest level since Wednesday's close and above its 20-day moving average.

2026-11-04 23:46; UTC

ZIM Integrated Shipping Services Ltd is trading lower in after-market hours, continuing its downward trend from Wednesday's close and positioned 3.49% below its 20-day moving average.

2026-11-04 23:46; UTC

News

UBS maintains Neutral rating on Coca-Cola Europacific Partners PLC and raises price target to $115 in a report published after the market closed.

2026-11-04 23:46; UTC

The NZD/CAD is trading modestly higher, supported by stronger-than-expected ADP Employment Change data, which reported an increase of 86k jobs in October.

2026-11-04 23:46; UTC

GBP/NZD is lower, reflecting a decline since Tuesday's close.S. employment and services data.

2026-11-04 23:46; UTC

Arbor Realty Trust, Inc. traded roughly flat in after-market hours, remaining near the lower end of its one-month range and below its 20-day moving average.

2026-11-04 23:42; UTC

Lincoln Electric Holdings, Inc. is trading lower in after-market hours, reversing an initial gain and marking a fourth consecutive daily decline.

2026-11-04 23:42; UTC

Alector, Inc. is declining sharply in after-market trading, reaching its lowest point of the day after previously showing strength above its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

123.88% į viršų

12 mėnesių prognozė

Vidutinis 4.5 USD  123.88%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

4

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat